Arca
Skip to content

Atellica CH Diazo Total Bilirubin (D_TBil)

Diazo Colorimetry, Bilirubin. 510(k) K251998, from Siemens Healthcare Diagnostics, Inc. (Newark, DE). Product code CIG, class 2.

As of Nov 17, 2026, K251998 is an FDA 510(k) held by Siemens Healthcare Diagnostics, Inc., substantially equivalent on Feb 27, 2026 after 245 days, with no recalls tied to it in FDA's recall database.

  • Substantially equivalent: Feb 27, 2026
  • Review time: 245 days
  • Recalls: 0

Indications for Use

As the 510(k) summary states them, read from FDA's summary PDF

The Atellica CH Diazo Total Bilirubin (D_TBil) assay is for in vitro diagnostic use in the quantitative determination of total bilirubin in human serum and plasma of adults and neonates using the Atellica CH Analyzer.

Predicate Devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Other CIG Clearances

The newest 510(k)s for the same product code; their median review was 245 days; see every CIG device

Record

Type
Traditional
Received
Jun 27, 2025
Review panel
Clinical Chemistry
Regulation
21 CFR 862.1110

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.